tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Mara Goldstein, 130 are a BUY (74.29%), 43 are a HOLD (24.57%), 2 are a SELL (1.14%).
Analyst Mara Goldstein, currently employed at MIZUHO, carries an average stock price target met ratio of 47.29% that have a potential upside of 41.27% achieved within 251 days.
Mara Goldstein’s has documented 335 price targets and ratings displayed on 39 stocks. The coverage is on Healthcare, Communication Services sectors.
Most recent stock forecast was given on KURA, Kura Oncology at 18-May-2025.
Analyst best performing recommendations are on FTSV (FORTY SEVEN).
The best stock recommendation documented was for CRVS (CORVUS PHARMACEUTICALS) at 3/30/2023. The price target of $3.5 was fulfilled within 69 days with a profit of $2.71 (343.04%) receiving and performance score of 49.72.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$101
$-7.24 (-6.69%)
$101
5 years 11 months 23 days ago
(31-Oct-2019)
2/8 (25%)
$-7.53 (-6.94%)
171
Hold
$115
$6.76 (6.25%)
$102
5 years 11 months 23 days ago
(31-Oct-2019)
3/12 (25%)
$6.47 (5.96%)
382
Hold
$102
5 years 11 months 23 days ago
(31-Oct-2019)
1/1 (100%)
$18.78 (22.57%)
322
Hold
$100
$-8.24 (-7.61%)
$128
6 years 2 months 5 days ago
(18-Aug-2019)
3/6 (50%)
$4.78 (5.02%)
159
Buy
$102
$-6.24 (-5.76%)
$105
6 years 5 months 21 days ago
(02-May-2019)
4/4 (100%)
$5.12 (5.28%)
207
Which stock is Mara Goldstein is most bullish on?
Which stock is Mara Goldstein is most reserved on?
What Year was the first public recommendation made by Mara Goldstein?
